Navigation Links
Medipacs Initial Financing
Date:5/27/2008

TUCSON, Ariz., May 27 /PRNewswire/ -- Medipacs, Inc., a Tucson, Arizona based medical device company, announced today that is has secured an initial financial investment of $1.65 million. The financing has been provided by Mesa Verde Venture Partners and other investors in Tucson, San Diego, Phoenix and Washington D.C.

Medipacs Inc. CEO, Mark McWilliams comments: "We are very pleased with the tremendous response by interested investors in our novel disposable infusion technology and the unique business model we have developed for its commercialization."

Mesa Verde's Managing Member, Daniel C. Wood, CFA, states, "We have a high regard for the team, the science and the Board assembled by the Company We are very pleased to be the first institutional investor in Medipacs."

Mesa Verde Venture Partners is a biomedical, seed/start-up venture capital fund based in San Diego, with Venture Partners in Utah, Arizona and New Mexico.

For additional company information, please contact Kent Smith, Vice President of Marketing at 858 228 0348.

Medipacs, Inc. is a Tucson based early-stage medical device company with expertise in hydrogel polymers. It is developing advanced infusion technologies and is now focused on its first commercial application, a programmable disposable infusion device. Medipacs is a client at the Arizona Center for Innovation (AzCI), located at the University of Arizona Science and Technology Park in Tucson, AZ. For information about AzCI, please contact Marie Wesselhoft, Director, at: (520) 382-3265.


'/>"/>
SOURCE Medipacs, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Innolife Pharma Provides Initial Update on Negotiations for Significant Product Joint Venture
2. Thermage, Inc. Announces Initial Shipments of Cellulite Product
3. MHA Announces Initial Results of the Specialty Pharmacy Member Profile Initiative
4. Perrigo Company Announces Initial Shipments of Store Brand Omeprazole Tablets
5. Harman/Becker Automotive Systems Completes Initial Deployments of Visiprise Integrated Manufacturing Execution
6. IPC The Hospitalist Company, Inc. Prices Initial Public Offering
7. Accuro Healthcare Solutions, Inc. Files Registration Statement for Proposed Initial Public Offering
8. QLT Inc. announces initial steps in strategic restructuring
9. Alma Lasers Announces Proposed Initial Public Offering
10. HearAtLast Announces Completion of Initial Private Placement Financing Totaling US $1,000,000
11. Virtual Radiologic Corporation Announces Closing of Initial Public Offering and Exercise of Option to Purchase Additional Shares
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... 08, 2016 , ... Stephanie Hebert Insurance Agency, serving families ... new charity campaign. As part of their ongoing community involvement program, funds are ... that children deserve a voice, and in the spirit of neighbors helping neighbors ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... expansion into Canada to provide its range of unique and advantaged protective ... Quebec City that will provide bilingual customer service and marketing support. A new ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... announced today that nominations will be accepted February 8, 2016 through May ... , Awards include the Information Security Executive® of the Year, which recognizes ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... lower incidence rate of type 2 diabetes in the GrassrootsHealth cohort with substantially ... to make a change in public health,” states Carole Baggerly, Director of GrassrootsHealth, ...
(Date:2/8/2016)... , ... February 08, 2016 , ... The schedule ... in this country. The AutismOne 2016 Conference, which is being held May 25-29 at ... won’t hear elsewhere about helpful interventions and causes of chronic illness in children. , ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... , Feb. 8, 2016  Sangamo BioSciences, ... therapeutic genome editing, announced that the U.S. Food ... Investigational New Drug (IND) application for SB-318, a ... therapy for Mucopolysaccharidosis Type I (MPS I). The ... Sangamo to initiate a Phase 1/2 clinical study ...
(Date:2/8/2016)... February 8, 2016 ... published by Allied Market Research titled, "World ... Forecasts, 2014-2020", estimates the world synthetic biology market ... and sequencing technology segment would continue to lead ... tools segment, collectively, held around half of the ...
(Date:2/8/2016)... HOUSTON , 8. Februar 2016 /PRNewswire/ ... veröffentlichte heute eine Infografik mit dem Titel ... ganzen Welt), mit der der Krankheit gegenüber ... die dazu ermutigen soll, Medikamentenresistenz bei Epilepsie ... der allgemeinen Diskussion zu machen. Mithilfe der ...
Breaking Medicine Technology: